Cargando…
Optic nerve head perfusion changes in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab or photocoagulation: a randomized controlled trial
BACKGROUND: Proliferative diabetic retinopathy (PDR) is a serious sight-threatening disease, and half of the patients with high-risk PDR can develop legal blindness within 5 years, if left untreated. This study was aimed at comparing panretinal photocoagulation (PRP) and intravitreal ranibizumab inj...
Autores principales: | Helmy, Ahmed Magdy Raffat, Rashad, Mohammad Ahmad, Gharieb, Hesham Mohamed, Gomaa, Wael Adel, Zaki, Rania Gamal Eldin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Virtual Ophthalmic Research Center
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460245/ https://www.ncbi.nlm.nih.gov/pubmed/37641606 http://dx.doi.org/10.51329/mehdiophthal1459 |
Ejemplares similares
-
Combination of Intravitreal Ranibizumab and Laser Photocoagulation for Aggressive Posterior Retinopathy of Prematurity
por: Mota, Ágata, et al.
Publicado: (2012) -
Combination therapy of intravitreal ranibizumab and laser photocoagulation for aggressive posterior retinopathy of prematurity
por: Dudani, Ajay I, et al.
Publicado: (2022) -
Combination of Intravitreal Injection of Ranibizumab and Photocoagulation for the Treatment of Aggressive Posterior Retinopathy of Prematurity with Vitreous Hemorrhage
por: Xu, Yu, et al.
Publicado: (2016) -
Structural and refractive outcomes of intravitreal ranibizumab followed by laser photocoagulation for type 1 retinopathy of prematurity
por: Hoppe, Charis, et al.
Publicado: (2022) -
Efficacy of intravitreal bevacizumab combined with pan retinal photocoagulation versus panretinal photocoagulation alone in treatment of proliferative diabetic retinopathy
por: Sameen, Murtaza, et al.
Publicado: (2017)